Page
%P
1 Result(s)
within
Yasuyoshi Morita
English
Cancer Research
Oncology
Surgical Oncology
-
Article
Open AccessGilteritinib versus chemotherapy in Japanese patients with FLT3-mutated relapsed/refractory acute myeloid leukemia
Until recently, no effective targeted therapies for FLT3-mutated (FLT3mut+) relapsed/refractory (R/R) acute myeloid leukemia (AML) were available in Japan. The FLT3 inhibitor, gilteritinib, was approved in Japan ...
